Related Experiment Videos

Lif, the lysostaphin immunity factor, complements FemB in staphylococcal peptidoglycan interpeptide bridge formation

M Tschierske1, K Ehlert, A M Strandén

  • 1Institute of Medical Microbiology, University of Zürich, Switzerland.

Insights

The Staphylococcus aureus FemB protein

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Staphylococcus aureus peptidoglycan synthesis is crucial for bacterial cell wall integrity.
  • The pentaglycine interpeptide chain formation requires specific enzymes, FemA and FemB.
  • Methicillin resistance in S. aureus is linked to the FemA and FemB proteins.

Purpose of the Study:

  • To investigate the function of the lysostaphin immunity factor (Lif) in peptidoglycan synthesis.
  • To determine if Lif can substitute for FemA or FemB.
  • To assess the impact of Lif on methicillin resistance in S. aureus.

Main Methods:

  • Complementation assays using serine incorporation.
  • Assessing lysostaphin resistance in wild-type and mutant strains.
  • Evaluating Lif's effect on methicillin resistance.

Main Results:

  • Lif complemented the function of FemB, indicated by serine incorporation and increased lysostaphin resistance.
  • Lif could not substitute for FemA in femA or femAB-null mutants.
  • Lif did not complement methicillin resistance, suggesting serine-substituted side chains are poor substrates for PBP2'.

Conclusions:

  • Lif functionally complements FemB in Staphylococcus aureus peptidoglycan synthesis.
  • Lif's inability to complement FemA or methicillin resistance highlights specific roles for FemA and FemB.
  • The findings suggest implications for understanding antibiotic resistance mechanisms.

Related Concept Videos